Work Here?
Work Here?
Work Here?
Denali Therapeutics focuses on developing treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS, which involve the gradual loss of nerve cells leading to serious health issues. The company uses scientific research to understand the biological pathways that contribute to these diseases, aiming to create drugs that target specific molecules in the body. Denali stands out from competitors by combining its own research efforts with strategic partnerships with other biotech firms and pharmaceutical companies, allowing for shared resources and knowledge. The goal of Denali Therapeutics is to create effective treatments that improve the lives of patients suffering from these debilitating conditions.
Company Stage
IPO
Employees
201-500
Industries
Biotechnology, Healthcare
Total Funding
$1.1B
Headquarters
N/A
Founded
2015
Help us improve and share your feedback! Did you find this helpful?
Find jobs on Simplify and start your career today